Literature DB >> 18256419

Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis.

Luis A Marcos1, Martin Tagle, Angelica Terashima, Alejandro Bussalleu, Cesar Ramirez, Carlos Carrasco, Luis Valdez, Jorge Huerta-Mercado, David O Freedman, Joseph M Vinetz, Eduardo Gotuzzo.   

Abstract

Fascioliasis is highly endemic in the Andean region of South America. Newer serological assays have improved our ability to diagnose acute fascioliasis. The diagnosis was established by Fasciola hepatica serology (Fas2-ELISA or Western blot) in 10 patients. Identifiable exposure included ingestion of watercress (N = 8), alfalfa juice (N = 5), and lettuce (N = 1). Computed tomography of the abdomen showed hepatomegaly (N = 9), track-like hypodense lesions with subcapsular location (N = 8), and subcapsular hematoma (N = 2). Radiologic sequelae included cyst calcifications detectable at least 3 years after treatment. Stool examinations were negative for F. hepatica eggs; serology was positive (Arc II [N = 2], Fas2-ELISA [N = 6], Western blot [N = 2]). The syndrome of eosinophilia, fever, and right upper quadrant pain, elevated transaminases without jaundice, hypodense liver lesions on CT, and an appropriate exposure history suggests acute fascioliasis. Fascioliasis is specifically treatable with a single dose of triclabendazole.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256419

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Burden of Fasciola hepatica Infection among children from Paucartambo in Cusco, Peru.

Authors:  Martha Lopez; A Clinton White; Miguel M Cabada
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Human fascioliasis: a re-emerging disease in upper Egypt.

Authors:  Mohamed A Mekky; Mohammed Tolba; Mohamed O Abdel-Malek; Wael A Abbas; Mohamed Zidan
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

3.  Genotoxic potential of Fasciolagigantica infection in experimentally infected rabbits.

Authors:  M A Hannan Khan; P A A Shareef; Abdur Rehman; Rizwan Ullah; Lubna Rehman; S M A Abidi
Journal:  J Parasit Dis       Date:  2016-08-16

4.  [Multiple liver lesions accompanied by eosinophilia - a case report of fascioliosis].

Authors:  Eva Trifina; Johannes Spenger; Shahin Zandieh; Jörg Haller; Herbert Auer; Christian Osterreicher; Klaus Klaushofer; Peter Mikosch
Journal:  Wien Med Wochenschr       Date:  2011-09

5.  Domestically acquired fascioliasis in northern California.

Authors:  Scott A Weisenberg; David E Perlada
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

6.  Hepatic mass caused by Fasciola hepatica: a tricky differential diagnosis.

Authors:  Bülent Yilmaz; Seyfettin Köklü; Gökhan Gedikoglu
Journal:  Am J Trop Med Hyg       Date:  2013-09-30       Impact factor: 2.345

7.  Imported human fascioliasis, United Kingdom.

Authors:  Meera A Chand; Joanna S Herman; David G Partridge; Kirsten Hewitt; Peter L Chiodini
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

8.  Dot-blot immunoassay of Fasciola gigantica infection using 27 kDa and adult worm regurge antigens in Egyptian patients.

Authors:  Hanan H Kamel; Ghada A Saad; Rania M Sarhan
Journal:  Korean J Parasitol       Date:  2013-04-25       Impact factor: 1.341

9.  Eosinophilic granulomatous gastrointestinal and hepatic abscesses attributable to basidiobolomycosis and fasciolias: a simultaneous emergence in Iraqi Kurdistan.

Authors:  Hemmin A Hassan; Runnak A Majid; Nawshirwan G Rashid; Bryar E Nuradeen; Qalandar H Abdulkarim; Tahir A Hawramy; Rekawt M Rashid; Alton B Farris; Jeannette Guarner; Michael D Hughson
Journal:  BMC Infect Dis       Date:  2013-02-20       Impact factor: 3.090

10.  Sporadic incidence of Fascioliasis detected during hepatobiliary procedures: a study of 18 patients from Sulaimaniyah governorate.

Authors:  Tahir Abdullah Hussein Hawramy; Kamal Ahmed Saeed; Seerwan Hama Sharif Qaradaghy; Taha Ahmed Karboli; Beston Faiek Nore; Noora Hisham Abood Bayati
Journal:  BMC Res Notes       Date:  2012-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.